news
01-14-2025, 06:51 PM
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand (https://news.google.com/rss/articles/CBMingFBVV95cUxPQjFBaDNsaDlmMnlPRi1MSVQ2d2dVSDNSUE FpZHNPQjVMQWV4aWlBQXhhdXdCNXY4N3RSRHVhSzBvLUQxNkVC TGtGVHgtbVYzU2RTNEFpRlYwVVdDQWZaY3hDemlZY0xRb2FxTl ZiVDNBYkx0ZWU0cFZnZFBmRE03TGZXQktSNGg1OTg3YWl3ZFkw bWtwVUh4RnZsdHY5Z9IBowFBVV95cUxOekxDMVdDdU5HYXh5OX Y3UUdFbnJzTTkyWHJtOUVKaENqblBGZzJKYXpqdEtRTTUtR21z Zkx0dkw0WkQ0TzVvcmItdThDOFNUUE5ZQmZGRm9qRW9JUXBteT g3c21zaDUzNWQ2WUE3U1NVZDZYMWpvZkx3UXA2bmJFSWZhcFZD bGR1N2xMOENBdzFuZndzWUZNZ0R6ZVFSRVVmazQ4?oc=5) CNBC
Eli Lilly shares tumble after cutting its sales outlook. What it means for investors (https://news.google.com/rss/articles/CBMiqAFBVV95cUxQNHFkSjZzSV9MbzRaUGFqRnVhSEtRS0pMbT FEeXFfZ0JHbVRMcTkwc0hHbTcyTDJDUlctMnV2THhUSFRQdEct NklWQi1LaXl6NFJheUJ0eXNOTXJFSWZzc3BMNWlGUkI1bDZNOU VCNHRaeVhoTmdiMXpVNC02TDN6b2d6Ml9LSXJCSVhmTlhTdFhZ a0cxUi1reWVyd2xvU050YWtnNmkxcE0?oc=5) CNBC
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday (https://news.google.com/rss/articles/CBMifEFVX3lxTE5peFNGZFFzNmVGbS01TTBYc3ZsVFRRcVBJZn ZYZmd2Zm9kcXRiWVJTT0dvel9JT1h3ZUx0WXlOZ0tydDgyZmRI TjdtMU1OYzJaaEo0QnI5N1h1X2J5M2ZOdEtsRFJOV2tuTm9jel NJV1ZhVkVlUXRLMW13Ukk?oc=5) Yahoo Finance
Mounjaro and Zepbound sales disappoint, and Eli Lilly’s stock is dropping (https://news.google.com/rss/articles/CBMipAFBVV95cUxPQ1Y3eldXYjhjWHBNd2E5LWZnUnFXXy1xM0 9UNEkxaEozZDdDZzJNSjhWalZ2c3dYdVF4dXo1YktnWlVMTFVn TTQ1d0dELTdZckp5U3d1MWpOdlFCOGlFb1I2b3QzUHlzTWNmcE 41VlJMMkVtbnIxMXV5Q0I2WUdiRTlaWVBCaEtaQlk2NDV3TlZP bkF3UlNvNDhFVWN0ZTZpOGVxLdIBqgFBVV95cUxPNU1BakcyNG 1aSXQtdzk3LVNDSWpoZno1Zk85eWttNUJVeWthZ1hMdHBMOFVY TWJxQWtRdW9qc3pYVEZ1d2xMR1hIbWc3UDdGUGw2Tlk4TzRkMV VVSXRESFFvdWZqeEQxNVVqOHk0Tk9aZl9QZ21wTEhCYm42MHRU dlR0eG5XaGtRSnUwcDRYeE1XQmRrVFo3UkxIaGV2QnhPQklQRT JmN3ktQQ?oc=5) MarketWatch
Eli Lilly Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow (https://news.google.com/rss/articles/CBMikwFBVV95cUxNY0FwdHBPcl8wSTE0RHlXdmtUN3FJeVRwVn RHUkF3bDhodnI1enAybW9YN1J2ekVVb0NES25WSHowel9nb1Bu X2dkaVdEaS1VWGhPMnQxYWJrc1lZX3BveFV2ZFZPM3EyWkNrUn V3MUN0Qk1JVTNfbmVDcGUtSExmQlExUlBXdnNmX3k1OHhvUjZ2 bVk?oc=5) Investor's Business Daily
More... (https://news.google.com/rss/articles/CBMingFBVV95cUxPQjFBaDNsaDlmMnlPRi1MSVQ2d2dVSDNSUE FpZHNPQjVMQWV4aWlBQXhhdXdCNXY4N3RSRHVhSzBvLUQxNkVC TGtGVHgtbVYzU2RTNEFpRlYwVVdDQWZaY3hDemlZY0xRb2FxTl ZiVDNBYkx0ZWU0cFZnZFBmRE03TGZXQktSNGg1OTg3YWl3ZFkw bWtwVUh4RnZsdHY5Z9IBowFBVV95cUxOekxDMVdDdU5HYXh5OX Y3UUdFbnJzTTkyWHJtOUVKaENqblBGZzJKYXpqdEtRTTUtR21z Zkx0dkw0WkQ0TzVvcmItdThDOFNUUE5ZQmZGRm9qRW9JUXBteT g3c21zaDUzNWQ2WUE3U1NVZDZYMWpvZkx3UXA2bmJFSWZhcFZD bGR1N2xMOENBdzFuZndzWUZNZ0R6ZVFSRVVmazQ4?oc=5)
Eli Lilly shares tumble after cutting its sales outlook. What it means for investors (https://news.google.com/rss/articles/CBMiqAFBVV95cUxQNHFkSjZzSV9MbzRaUGFqRnVhSEtRS0pMbT FEeXFfZ0JHbVRMcTkwc0hHbTcyTDJDUlctMnV2THhUSFRQdEct NklWQi1LaXl6NFJheUJ0eXNOTXJFSWZzc3BMNWlGUkI1bDZNOU VCNHRaeVhoTmdiMXpVNC02TDN6b2d6Ml9LSXJCSVhmTlhTdFhZ a0cxUi1reWVyd2xvU050YWtnNmkxcE0?oc=5) CNBC
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday (https://news.google.com/rss/articles/CBMifEFVX3lxTE5peFNGZFFzNmVGbS01TTBYc3ZsVFRRcVBJZn ZYZmd2Zm9kcXRiWVJTT0dvel9JT1h3ZUx0WXlOZ0tydDgyZmRI TjdtMU1OYzJaaEo0QnI5N1h1X2J5M2ZOdEtsRFJOV2tuTm9jel NJV1ZhVkVlUXRLMW13Ukk?oc=5) Yahoo Finance
Mounjaro and Zepbound sales disappoint, and Eli Lilly’s stock is dropping (https://news.google.com/rss/articles/CBMipAFBVV95cUxPQ1Y3eldXYjhjWHBNd2E5LWZnUnFXXy1xM0 9UNEkxaEozZDdDZzJNSjhWalZ2c3dYdVF4dXo1YktnWlVMTFVn TTQ1d0dELTdZckp5U3d1MWpOdlFCOGlFb1I2b3QzUHlzTWNmcE 41VlJMMkVtbnIxMXV5Q0I2WUdiRTlaWVBCaEtaQlk2NDV3TlZP bkF3UlNvNDhFVWN0ZTZpOGVxLdIBqgFBVV95cUxPNU1BakcyNG 1aSXQtdzk3LVNDSWpoZno1Zk85eWttNUJVeWthZ1hMdHBMOFVY TWJxQWtRdW9qc3pYVEZ1d2xMR1hIbWc3UDdGUGw2Tlk4TzRkMV VVSXRESFFvdWZqeEQxNVVqOHk0Tk9aZl9QZ21wTEhCYm42MHRU dlR0eG5XaGtRSnUwcDRYeE1XQmRrVFo3UkxIaGV2QnhPQklQRT JmN3ktQQ?oc=5) MarketWatch
Eli Lilly Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow (https://news.google.com/rss/articles/CBMikwFBVV95cUxNY0FwdHBPcl8wSTE0RHlXdmtUN3FJeVRwVn RHUkF3bDhodnI1enAybW9YN1J2ekVVb0NES25WSHowel9nb1Bu X2dkaVdEaS1VWGhPMnQxYWJrc1lZX3BveFV2ZFZPM3EyWkNrUn V3MUN0Qk1JVTNfbmVDcGUtSExmQlExUlBXdnNmX3k1OHhvUjZ2 bVk?oc=5) Investor's Business Daily
More... (https://news.google.com/rss/articles/CBMingFBVV95cUxPQjFBaDNsaDlmMnlPRi1MSVQ2d2dVSDNSUE FpZHNPQjVMQWV4aWlBQXhhdXdCNXY4N3RSRHVhSzBvLUQxNkVC TGtGVHgtbVYzU2RTNEFpRlYwVVdDQWZaY3hDemlZY0xRb2FxTl ZiVDNBYkx0ZWU0cFZnZFBmRE03TGZXQktSNGg1OTg3YWl3ZFkw bWtwVUh4RnZsdHY5Z9IBowFBVV95cUxOekxDMVdDdU5HYXh5OX Y3UUdFbnJzTTkyWHJtOUVKaENqblBGZzJKYXpqdEtRTTUtR21z Zkx0dkw0WkQ0TzVvcmItdThDOFNUUE5ZQmZGRm9qRW9JUXBteT g3c21zaDUzNWQ2WUE3U1NVZDZYMWpvZkx3UXA2bmJFSWZhcFZD bGR1N2xMOENBdzFuZndzWUZNZ0R6ZVFSRVVmazQ4?oc=5)